InspireMD (NSPR) Misses Q2 EPS by 2c

InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• SpaceX retail investors turn sellers for first time since IPO
• Citi Trends reports 10.9% Q2 sales rise ahead of earnings call
• Raymond James Downgrades Russel Metals Inc. (RUS:CN) (RUSMF) to Market Perform